The Genetic Factors in the Development of Atrial Fibrillation

Authors

Zulfiya KachiyevaZulfiya   Kachiyeva ORCID1, Aiganym Tolegenkyzy1, Timur SalievTimur  Saliev ORCID1, Shynar TanabayevaShynar Tanabayeva ORCID1, Baimakhan Tanabayev Baimakhan Tanabayev  ORCID2, Bakhyt RamazanovaBakhyt Ramazanova ORCID1, Ildar FakhradiyevIldar Fakhradiyev ORCID1,*
1S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
2South-Kazakhstan Medical Academy, Shymkent, Kazakhstan
*Corresponding Author: Ildar Fakhradiyev, S.D. Asfendiyarov Kazakh National Medical University, Tole Bi Street 94, Almaty, 050000, Kazakhstan. Tel: +7-7075001190 Email: [email protected]

International Cardiovascular Research Journal:Vol. 15, issue 1; e108440
Published online:Mar 15, 2021
Article type:Review Article
Received:Aug 10, 2020
Accepted:Nov 14, 2020
How to Cite:Kachiyeva Z, Tolegenkyzy A, Saliev T, Tanabayeva S, Tanabayev B, et al. The Genetic Factors in the Development of Atrial Fibrillation. Int Cardiovasc Res J. 2021;15(1):e108440. doi:

Abstract

Context:
Atrial Fibrillation (AF) is the most prevalent arrhythmia in human populations with a growing world-wide burden. The present review aimed to determine the genetic factors in the development of AF.
Evidence Acquisition:
The present study included the studies, which probed into the genetic factors of AF. The searches were done in PubMed, Scopus, Web of Science, Embase, and Google Scholar databases. The review highlighted two main directions of AF genetic studies; i.e., rare mutations in structural genes, including potassium and sodium channels, connexins, and transcription factors genes, and genome-wide association studies of significant common variants. The main focus was on the most important loci confirmed by numerous studies with both rare and common variants.
Results:
Research on the genetic basis of AF has remained a hot topic due to its growing worldwide burden. Recent advances in genome-wide studies have provided the ground for gaining insight on minor genetic factors with cumulative effects, which are distributed more widely than previously known rare mutations.
Conclusions:
Far more potential candidate genes and/or regulatory sequences have been already discovered, and there are much more to be explored in the near future. This will potentially result in a better understanding of AF and other arrhythmic conditions as well as their impacts on human health, and will provide new ways to improve diagnostics and treatment strategies.
 

Highlights

Fulltext

 
 
The full-text is available in pdf.
 
 
 
 
 
 
 

References

  • 1.
    The references are available in pdf.

Copyright

© 2021, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

1
Dec
2014

Focal Treatment for Genetic Disorders (A Fairy Tale or a True Story?)

Mohammad hossein Nikoo,
Mohammad Vahid Jorat,
Amir Aslani

Nikoo MH, Jorat MV, Aslani A. Focal Treatment for Genetic Disorders (A Fairy Tale or a True Story?). Int Cardiovasc Res J. 2017;8(4):e11673. doi:

12
Aug
2018
Gene-Finding Strategy in Glaucoma

Gene-Finding Strategy in Glaucoma

Mehrnaz Narooie-Nejad

Narooie-Nejad M. Gene-Finding Strategy in Glaucoma. Gene Cell Tissue. 2018;5(2):e74203. doi: https://doi.org/10.5812/gct.74203

7
May
2019

9P21.3 locus; An Important Region in Coronary Artery Disease: A Panel Approach to Investigation of the Coronary Artery Disease Etiology

Soodeh Omidi,
Fatemeh Ebrahimzadeh,
Samira Kalayinia

Omidi S, Ebrahimzadeh F, Kalayinia S. 9P21.3 locus; An Important Region in Coronary Artery Disease: A Panel Approach to Investigation of the Coronary Artery Disease Etiology. Int J Cardiovasc Pract. 2019;4(2):e130551. doi: https://doi.org/10.29252/ijcp-25001

25
Dec
2017

CYP2C9*1*2 and VKORC1-1639 AA Polymorphisms Correlation with Warfarin Dose Requirement: A Case Report

Zohreh Hoseinkhani,
Reza Khodarahmi,
Mona Sadeghalvad,
Fathemeh Norooznezhad,
Kamran Mansouri

Hoseinkhani Z, Khodarahmi R, Sadeghalvad M, Norooznezhad F, Mansouri K. CYP2C9*1*2 and VKORC1-1639 AA Polymorphisms Correlation with Warfarin Dose Requirement: A Case Report. J Rep Pharm Sci. 2018;7(1):e147605. doi:

29
Mar
2024
Clustering Patients with Paroxysmal Atrial Fibrillation

Clustering Patients with Paroxysmal Atrial Fibrillation

Behrooz Farzanegan,
Nasser Malekpour Alamdari,
Navid Nuraei,
Mohammad Fathi

Farzanegan B, Malekpour Alamdari N, Nuraei N, Fathi M. Clustering Patients with Paroxysmal Atrial Fibrillation. J Crit Care Excell. 2024;1(1):e148597. doi: https://doi.org/10.5812/jcce-148597

More by these authors

Zulfiya KachiyevaPubMedScholar
Aiganym TolegenkyzyPubMedScholar
Timur SalievPubMedScholar
Shynar TanabayevaPubMedScholar
Baimakhan TanabayevPubMedScholar
Bakhyt RamazanovaPubMedScholar
Ildar FakhradiyevPubMedScholar
Share
Cited by
Metrics
Indexed in